insights_auto
Why is PEB down 2.17%?
Dive Deeperchevron_right
PEB:ASX
Pacific Edge Ltd
A$0.22
arrow_downward
-2.17%(-0.0050) 1D
Nov 16, 1:22:05 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEB...
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
Open
A$0.23
High
A$0.23
Low
A$0.22
Mkt. cap
348.73M
Avg. vol.
54.06K
Volume
10.10K
52-wk high
A$0.26
52-wk low
A$0.12
No. of employees
114
News stories
From web sources and news partners
MarketWatch
·
57 minutes ago
Stock Market Today: Dow, S&P 500 and Nasdaq are set to fall as investors await Nvidia results and Anthropic's IPO this week: live updates
Investing.com
·
47 minutes ago
Morgan Stanley raises S&P 500 target on earnings growth, lower oil and AI adoption
The Motley Fool
·
2 hours ago
The S&P 500 Looks Cheaper Than It Has in Over 3 Years, but There’s a Catch
Billionaires.Africa
·
2 minutes ago
Billionaire Elon Musk's SpaceX eyes S&P 500 via Tesla deal
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitepacificedgedx.com